nano-dysferlin encoding AAV gene therapy (Tamid Bio)

N/A

Report date: 2025/01/26 19:04:33

Base Information

Drug Namenano-dysferlin encoding AAV gene therapy (Tamid Bio)
Drug Alias Namenano-dysferlin encoding AAV gene therapy (University of North Carolina)AAV-Nano-Dysferlinnano-dysferlin encoding AAV gene therapy (Tamid Bio)
ClassificationBiologics
Mechanisms of ActionDysferlin gene transference
TargetsDysferlin
Therapy Area/IndicationsMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina, Greensboro
China Registration ClassN/A

Develop Information

Active CompaniesTamid Bio Inc
Inactive CompaniesUniversity Of North Carolina, Greensboro
Active IndicationsMuscular Dystrophies, Limb-Girdle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A